PDL BioPharma, Inc. PDLIV
NASDAQ
Recommendation
Dividend Power Score
Day's Range
Latest Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
--
| 08/31/2020 | 06/30/2020 | 03/31/2020 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 105.45M | 125.51M | ||
| Total Receivables | -- | 58.75M | 60.44M | ||
| Inventory | -- | 12.63M | 10.54M | ||
| Prepaid Expenses | -- | 29.29M | 22.01M | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | 289.43M | 332.75M | ||
| Total Current Assets | -- | 495.55M | 551.26M | ||
|
|
|||||
| Total Current Assets | -- | 495.55M | 551.26M | ||
| Net Property, Plant & Equipment | -- | 3.04M | 3.26M | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | 12.55M | 12.88M | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | 4.09M | 9.77M | ||
| Total Assets | -- | 520.66M | 659.80M | ||
|
|
|||||
| Total Accounts Payable | -- | 3.52M | 5.23M | ||
| Total Accrued Expenses | -- | 12.67M | 10.10M | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | 20.04M | 26.42M | ||
| Total Other Current Liabilities | -- | 20.04M | 26.42M | ||
| Total Current Liabilities | -- | 36.24M | 41.74M | ||
|
|
|||||
| Total Current Liabilities | -- | 36.24M | 41.74M | ||
| Long-Term Debt | -- | 13.51M | 13.30M | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | 50.91M | 51.64M | ||
| Total Liabilities | -- | 100.66M | 106.69M | ||
|
|
|||||
| Common Stock & APIC | -- | 1.14M | 1.21M | ||
| Retained Earnings | -- | 485.49M | 621.13M | ||
| Treasury Stock & Other | -- | -66.16M | -69.11M | ||
| Total Common Equity | -- | 420.47M | 553.23M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -- | 420.47M | 553.23M | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -467.00K | -110.00K | ||
| Total Equity | -- | 420.00M | 553.12M | ||
|
|
|||||